Related Experiment Videos
Exploring inflammation in hemodialysis patients: persistent and superimposed inflammation. A longitudinal study
George Tsirpanlis1, Pantelis Bagos, Dimitris Ioannou
1Renal Unit, Alexandra General Hospital, Faculty of Biology, University of Athens, Athens, Greece. tsipg@hellasnet.gr
Kidney & Blood Pressure Research
|December 24, 2003
Summary
Hemodialysis patients experience persistent low-grade inflammation (microinflammation) and episodic inflammation from clinical events. Both contribute to cardiovascular disease risk.
Area of Science:
- Nephrology
- Cardiovascular Medicine
- Immunology
Background:
- Inflammation is common and episodic in hemodialysis (HD) patients, potentially linked to high cardiovascular disease (CVD) morbidity.
- The episodic nature of inflammation in HD patients, whether due to temporal variations or acute phase responses, requires longitudinal investigation.
Purpose of the Study:
- To explore the forms, characteristics, and causes of inflammation in HD patients.
- To investigate the relationship between inflammation patterns and cardiovascular disease (CVD) risk in HD patients.
Main Methods:
- Weekly measurements of high-sensitivity C-reactive protein (hs-CRP), serum amyloid A (SAA), and interleukin-6 (IL-6) in 37 HD patients over 16 weeks.
- Recording of clinical events in the week preceding each measurement.
- Statistical analysis using repeated measures ANOVA.
Main Results:
- Clinical events significantly influenced acute-phase proteins and IL-6 levels.
- Inflammatory indices showed significant temporal variation independent of clinical events.
- Mean hs-CRP was substantially higher during weeks with clinical events compared to event-free weeks.
Conclusions:
- HD patients exhibit persistent microinflammation that fluctuates over time, even in the absence of clinical events.
- Episodic inflammation, triggered by clinical events, is superimposed on this background microinflammation.
- Both persistent microinflammation and event-related inflammation may contribute to the high CVD morbidity observed in HD patients.